E.g., 04/15/2021
E.g., 04/15/2021
Title Category Credit Event Date Price
Big Data and 'Omics' Analysis in Urology (2020) $149.00 This course provides participants with an introduction to systems biology along with insights into the methods used to generate large datasets using ‘omics’ technologies, and the bioinformatics tools required for analysis. Despite the power of genomic, transcriptomic, and proteomic technologies, most researchers do not have the necessary computational expertise to analyze or interpret high content datasets unaided. Furthermore, many investigators are unaware of the unique challenges involved in experimental design as it pertains to systems-wide analyses.
Case-Based Discussion of AUA Non-Muscle Invasive Bladder Cancer Guidelines Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Improved understanding and rationale for diagnostic and therapeutic interventions for non invasive and invasive bladder cancer; heightened awareness of multidisciplinary efforts necessary for optimal care; algorithms and sources of information to provide to staff and patients.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:AstellasAstraZenecaBristol-Myers SquibbGenentechMerckPfizer, Inc.Sanofi Genzyme
Case-Based Discussion: BCR and mHSPC & M0 CRPC Podcast (2020)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC). 
Case-Based Discussion: Early M1 CRPC Management & Advanced M1 CRPC Podcast (2020)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC). 
Case-Based Discussion: Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy and End-of-Life Care Podcast (2020)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC). 
Chemo-ablation of Upper-Tract Urothelial Podcast (2020)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will review management options for advanced prostate, bladder, and kidney cancer using evidence-based recommendations and guidelines. The trials and literature that helped to shape the guidelines will be included. Included will be older, more established therapies as well as newer treatments, including checkpoint inhibitors and antibody-drug conjugates. Learners will become familiar with not only the therapies and their mechanisms, but the data behind their approval as well as future directions.
Clinical Cases in Urology: Diagnosis and Treatment of Early Stage Testicular Cancer (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based case scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA Guideline, Diagnosis and Treatment of Early Stage Testicular Cancer. 
Clinical Cases in Urology: Incontinence after Prostate Treatment (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/SUFU Guideline, Incontinence after Prostate Treatment.
Clinical Cases in Urology: Recurrent Uncomplicated Urinary Tract Infections in Women (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/CUA/SUFU Guideline, Recurrent Uncomplicated Urinary Tract Infections in Women.
Common Dilemmas in Prostate Cancer Detection and Management Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Course participants will:Optimally use PSA and other biomarkers to minimize unnecessary testing and biopsy when screening men who are at average risk for prostate cancer.Understand the principles of “risk-adapted” screening for men at elevated risk for prostate cancer based on race, family history, early in life PSA, polygenic risk scores, and specific genetic mutations (eg BRCA1/2).Understand the roles of MRI, high frequency ultrasound and novel transperineal approaches to improve prostate biopsy.
Contemporary Pharmacotherapy for OAB 2020: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active investigation and innovation. Patient communication, including goal setting with respect to realistic expectations of therapy, and therapeutic algorithms are important factors in improving patient outcomes.
CPS Castration-Resistant Prostate Cancer Amendment (2018)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. The goal of this Guideline is  to provide a rational basis for treatment of patients with CRPC, based on currently available published data.
CPS Erectile Dysfunction (2018)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction (ED).
CPS Evaluation and Management of Testosterone Deficiency (2018)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. The Evaluation and Management of Testosterone Deficiency AUA Guideline provides guidance to the practicing clinician on how to diagnose, treat and monitor the adult male with testosterone deficiency. 

Pages